Orlando Dermatology Aesthetic and Clinical (ODAC) Conference
In-Person Event
Jan 13 - 16, 2017
Miami, Florida, USASpeakers
OVERVIEW
Orlando Dermatology Aesthetic and Clinical (ODAC) Conference is organized by Orlando Dermatology Aesthetic and Clinical (ODAC) and would be held during Jan 13 - 16, 2017 at Trump National Doral Miami - Miami, Florida, United States of America. The target audience for this medical event is basically for dermatologists, dermatology residents, fellows and young practitioners, dermatology nurse practitioners and physician assistants, and other physicians with an interest in management of cutaneous diseases, disorders and the aesthetic treatment of adult patients of all skin types. This cme conference has been approved with 30 AMA PRA Category 1 Credit(s).
Upon completion of this live activity participants should be able to :
• Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma.
• Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types.
• Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance.
• Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes.
• Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment.
• Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype.
• Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy.
• Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis.
• Summarize the recently published AAD clinical guidelines on the management of atopic dermatitis
• Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease.
• Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection
• Identify the psoriasis patient population that would benefit most from treatment with biologic response modifiers
• Indicate the types of superficial fungal infection presenting in the dermatology setting
• Formulate optimal treatment plans for difficult to treat onychomycosis and cutaneous superficial fungal infections including tinea pedis, tinea cruris and tinea corporis
Upon completion of this live activity participants should be able to :
• Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma.
• Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types.
• Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance.
• Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes.
• Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment.
• Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype.
• Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy.
• Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis.
• Summarize the recently published AAD clinical guidelines on the management of atopic dermatitis
• Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease.
• Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection
• Identify the psoriasis patient population that would benefit most from treatment with biologic response modifiers
• Indicate the types of superficial fungal infection presenting in the dermatology setting
• Formulate optimal treatment plans for difficult to treat onychomycosis and cutaneous superficial fungal infections including tinea pedis, tinea cruris and tinea corporis
KEY DATES
13 Jan, 2017
Event Start Date
16 Jan, 2017
Event End Date
SPECIALITIES
DermatologySUGGESTED HOTELS
CONFERENCE VENUE
Trump National Doral MiamiRELATED CONFERENCES & LIVE WEBINARS
Quick Links